Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Net Cash Flow (2024 - 2025)

Historic Net Cash Flow for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to -$1.8 million.

  • Pyxis Oncology's Net Cash Flow rose 8606.54% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year change of. This contributed to the annual value of $9.8 million for FY2024, which is 10578.26% up from last year.
  • Per Pyxis Oncology's latest filing, its Net Cash Flow stood at -$1.8 million for Q3 2025, which was up 8606.54% from -$2.0 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Net Cash Flow ranged from a high of $18.3 million in Q1 2024 and a low of -$13.0 million during Q3 2024